|
NSCLC is a disease in which
cancer cells form in the tissues of the lung. These cells multiply to form
tumors in the lung and can spread to other parts of the body. NSCLC is said to
be “advanced” when it has spread to the lymph nodes, the other lung, or other
areas of the body.
Novartis Oncology is
currently conducting clinical trials to learn whether the study drug ASA404,
when given with other standard chemotherapy treatments, can improve survival in
patients with advanced NSCLC. Your physical state, changes in your cancer,
and laboratory findings observed during the trial will determine if ASA404 is
safe and effective in the treatment of advanced NSCLC.
|
For U.S. residents only.
Non-U.S. residents
